Literature DB >> 1849979

Production of dimer-specific and dengue virus group cross-reactive mouse monoclonal antibodies to the dengue 2 virus non-structural glycoprotein NS1.

A K Falconar1, P R Young.   

Abstract

A panel of mouse monoclonal antibodies (MAbs) raised against the non-structural glycoprotein NS1 of dengue 2 virus (PR159) was studied for cross-reactivity with the NS1 protein of other dengue virus serotypes and other members of the Flaviviridae using immunoblotting. Most of the 35 anti-NS1 MAbs were found to be specific for dengue 2 virus NS1 (some of which were specific for the native, dimeric form of this protein), but others were found to cross-react within the dengue virus group. This latter group of MAbs, although dominated by MAbs defining a dengue 2 and 4 virus subgroup, also contained some MAbs that were shown to cross-react with both linear (sequential) and conformational epitopes common to the NS1 glycoproteins of all four dengue virus serotypes. Several of these MAbs were also able to cross-react with other flaviviruses, most notably viruses from the Japanese encephalitis antigenic complex. Although cross-reactive epitopes were previously demonstrated on this glycoprotein using polyclonal sera from dengue virus-infected animals and human, this is the first report of the isolation of MAbs which define these determinants and which will allow their further analysis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1849979     DOI: 10.1099/0022-1317-72-4-961

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  25 in total

1.  West Nile virus nonstructural protein NS1 inhibits complement activation by binding the regulatory protein factor H.

Authors:  Kyung Min Chung; M Kathryn Liszewski; Grant Nybakken; Alan E Davis; R Reid Townsend; Daved H Fremont; John P Atkinson; Michael S Diamond
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-28       Impact factor: 11.205

2.  Precise location of sequential dengue virus subcomplex and complex B cell epitopes on the nonstructural-1 glycoprotein.

Authors:  A K Falconar; P R Young; M A Miles
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

3.  Altered enzyme-linked immunosorbent assay immunoglobulin M (IgM)/IgG optical density ratios can correctly classify all primary or secondary dengue virus infections 1 day after the onset of symptoms, when all of the viruses can be isolated.

Authors:  Andrew K I Falconar; Elsa de Plata; Claudia M E Romero-Vivas
Journal:  Clin Vaccine Immunol       Date:  2006-09

4.  Analysis of human monoclonal antibodies generated by dengue virus-specific memory B cells.

Authors:  Heather Friberg; Smita Jaiswal; Kim West; Marvin O'Ketch; Alan L Rothman; Anuja Mathew
Journal:  Viral Immunol       Date:  2012-08-30       Impact factor: 2.257

5.  Dengue virus inhibits alpha interferon signaling by reducing STAT2 expression.

Authors:  Meleri Jones; Andrew Davidson; Linda Hibbert; Petra Gruenwald; Joerg Schlaak; Simon Ball; Graham R Foster; Michael Jacobs
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

6.  Adult-onset, chronic, cyclic thrombocytopenia in a Rhesus macaque (Macaca mulatta) after dengue virus vaccination and viral challenge.

Authors:  Galit H Frydman; Kelly A Metcalf Pate; Robert P Marini; Armelle M de Laforcade; Irene Bosch; Vasudevan Bakthavatchalu; Sureshkumar Muthupalani; Alton G Swennes; Claire E Lyons; Ronald G Tompkins; James G Fox
Journal:  Vet Clin Pathol       Date:  2017-05-18       Impact factor: 1.180

7.  Defining the levels of secreted non-structural protein NS1 after West Nile virus infection in cell culture and mice.

Authors:  Kyung Min Chung; Michael S Diamond
Journal:  J Med Virol       Date:  2008-03       Impact factor: 2.327

8.  Monoclonal antibodies that bind to common epitopes on the dengue virus type 2 nonstructural-1 and envelope glycoproteins display weak neutralizing activity and differentiated responses to virulent strains: implications for pathogenesis and vaccines.

Authors:  Andrew K I Falconar
Journal:  Clin Vaccine Immunol       Date:  2007-12-26

9.  Antibodies to envelope glycoprotein of dengue virus during the natural course of infection are predominantly cross-reactive and recognize epitopes containing highly conserved residues at the fusion loop of domain II.

Authors:  Chih-Yun Lai; Wen-Yang Tsai; Su-Ru Lin; Chuan-Liang Kao; Hsien-Ping Hu; Chwan-Chuen King; Han-Chung Wu; Gwong-Jen Chang; Wei-Kung Wang
Journal:  J Virol       Date:  2008-04-30       Impact factor: 5.103

10.  Dengue virus replicon expressing the nonstructural proteins suffices to enhance membrane expression of HLA class I and inhibit lysis by human NK cells.

Authors:  Oren Hershkovitz; Alon Zilka; Ahuva Bar-Ilan; Shai Abutbul; Andrew Davidson; Michela Mazzon; Beate M Kümmerer; Alon Monsoengo; Michael Jacobs; Angel Porgador
Journal:  J Virol       Date:  2008-05-28       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.